Navigation Links
Rutgers researchers show how the brain can protect against cancer
Date:6/9/2008

New Brunswick, NJ--Scientists have been aware for many years that if cancer patients are not able to deal with the stress associated with being sick, the cancer will progress faster than in calmer patients. To counteract this phenomenon, physicians encourage treatments that help cancer patients handle their stress. Scientists theorized that the stress relief may have come as a result of increased beta-endorphin peptide (BEP), the "feel good" hormones in the brain that are released during exercise, a good conversation, and many other aspects of life that give humans pleasure.

Researchers at Rutgers hypothesized that BEP producing neurons do not just make us feel good, but also play roles in regulating the stress response and immune functions to control tumor growth and progression. In a paper published today in the Proceedings of the National Academy of Science, Dr. Dipak K. Sarkar and his colleagues demonstrate the physical mechanisms that support their hypothesis.

"Our findings show promise for future therapeutic treatments for bolstering the immune function," said Sarkar, professor of animal sciences and director of the Endocrinology Program at the Rutgers School of Environmental and Biological Sciences, and principal investigator of the research project.

Previous research has shown that too few, or inactive, BEP neurons are associated with various diseases. For example, low numbers of BEP neurons have been identified in the brains of patients with depression and schizophrenia. Neurons that produce too little BEP are found in many obese patients. In both these cases the patients also had higher levels of infection and more incidence of cancer.

To test their hypothesis about the role of BEP in controling tumor growth and progression, the Rutgers scientists took neural stem cells, transformed them into BEP neurons by treating them with particular chemicals, and then transplanted them into brains of live rats. The aut
'/>"/>

Contact: Michele Hujber
hujber@aesop.rutgers.edu
732-932-7000
Rutgers University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. The Healthcare Foundation of NJ awards grant to Rutgers College of Nursings Rachel Jones
2. 2 Rutgers College of Nursing Ph.D students to receive FNSNA Fellowships
3. Rutgers College of Nursings Linda Flynn to receive N.J. Governors Nursing Merit Award
4. Rutgers research partner Stemcyte, Inc., expands to New Jersey
5. The Zonta Club of Essex County honors Rutgers College of Nursings Rachel Jones
6. Julia Quinlan to present awards at a conference hosted by Rutgers College of Nursing
7. Rutgers researchers unlock mysteries of vitamin A metabolism during embryonic development
8. NJSNA honors Rutgers College of Nursings Linda Flynn for excellence in research
9. Rutgers center sparks liquid bandage, a new frontline wound treatment
10. Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers-Newark Provost Award
11. Rutgers College of Nursing emerita professor Beverly Whipple receives FSSS book award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (...hey received $7.5 million pursuant to the joint ve...nc. to commercialize and develop Zevalin(R) in the...the initial $7.5 million payment in connection wit...y earn up to an additional $15 million in product ...
(Date:1/7/2009)...toward containing health care costs could have the...uctivity, impairing quality and perhaps even incre...ter physicians suggest in a New England Journal o...havioral economics and psychology, Pamela Hartzban...t assigning a monetary value to every aspect of a ...
(Date:1/7/2009)...Jan, 7 Natural Alternatives International, Inc. (...nufacturer and marketer of customized nutritional ...er 31, 2008 its former President, Randell Weaver,s...d it completed certain amendments to its credit fa... the amendments extend the maturity date for the w...
(Date:1/7/2009)...n. 7 WellPoint, Inc. (NYSE: WLP ) announced,tod...at the 27th Annual J.P.,Morgan Healthcare Conferen...,Time (12:30 p.m. Eastern Standard Time). , We...ults for the three,months ended Dec. 31, 2008, on ...a quiet period prior to this scheduled earnings re...
Breaking Medicine News(10 mins):Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 2Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 3Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 4Health News:Cost containment focus could have consequences for health care delivery 2Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2Health News:WellPoint Announces Appearance at Upcoming Conference 2
...w survey by Cancer Research UK says that obese peo...cancer and think they must slim down// only to loo...found that 40% thought looking good was the main r...ile 32% were aware that it lessened cancer risk. "...
... Ridge: The United States Department of Agricultur...he Special Supplemental Nutrition Program// for Wo.... The USDA's proposal will look at reducing the qu...of the food packages. The proposal has indicated t...
...ean-Congo Haemorrhagic Fever (CCHF) has killed at ... of it ever reported since it was identified// in ...s more cases of the Ebola-like disease are bound ... of this disease were reported. .Six provinces in ...
...w screening system combining digital photography w...tive method to screen for a common childhood oral ...er city toddlers. Early childhood dental caries...ottle tooth decay, results from prolonged exposure...
Other Medicine News:Health News:Proposal to revamp WIC food package 2Health News:Crimean-Congo Hemorrhagic Fever hits Turkey 2Health News:New Screening System For Early Detection Of Dental Caries in Toddlers 2Health News:New Screening System For Early Detection Of Dental Caries in Toddlers 3
(Date:1/6/2009)...RNewswire/ -- Pacira Pharmaceuticals, Inc., an,ac...ed today that enrollment,has been completed in tw...,safety and efficacy of a single intraoperative ad... prolonged postoperative analgesia. , Resul...al knee,arthroplasty (TKA) are expected to provid...
(Date:1/3/2009)...EMONT, Ill., Jan. 2 Mag...ogy providing an increasing number of clinical ben...ording to an article in the January 2009 issue of ... Surgeons ( http://www.jaaos.org/ ). It is predic...echnical developments will allow MRI to provide ev...
(Date:12/27/2008)...ar silence, offers to ease cloning costs for Clona...Dec. 27 Six years to th...d child, Dr. Brigitte Boisselier, head of the comp...ther babies cloned by her company are growing up h... families, privacy. , , "We,ve helped almost 10...
(Date:12/17/2008)...FirstCall/ -- Medivation, Inc.,(Nasdaq: MDVN ) ...llment in a,Phase 1-2 dose-escalation clinical tr...onist, in castration-resistant prostate cancer pat...S. Food and Drug Administration (FDA) to,advance ... open-label, U.S. Phase 1-2 study evaluated prosta...
Breaking Medicine Technology:Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3'We're Ready to Prove It!' 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday August 5 2008 24489 1Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday August 5 2008 24489 2DoctorDirectory to Co market VoSpire ER 28R 29 with DAVA Pharmaceuticals Inc 24486 1DoctorDirectory to Co market VoSpire ER 28R 29 with DAVA Pharmaceuticals Inc 24486 2InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 24483 1InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 24483 2InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 24483 3Poniard Pharmaceuticals Announces Upcoming Conference Participation 6783 1Poniard Pharmaceuticals Announces Upcoming Conference Participation 6783 2
...., May 09, 2007 /PRNewswire-FirstCall/ --,Catalyst...itive,initial, top-line results from a bioequivale...igabatrin Tablets) is bioavailable and,bioequivale...rketed,in Europe by Sanofi Aventis. These data pot...e extensive body of published pre-clinical,and cli...
...if.--(BUSINESS WIRE)--May 10, 2007 - According to,...65 percent of,female respondents seeking treatment...Painkillers such as Vicodin, OxyContin, Percocet,a...n, 35 percent of,the mothers who reported a depend... to Clare Waismann, registered addiction,specialis...
Other Medicine Technology:Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 2Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 3Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 4Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 2
Pneumatic impactor, general surgery, available in various hose connector styles.
The SmartDriver System consists of a pistol-grip handpiece available in Pneumatic, Electric and Battery Power, with a wide range of couplers that can be used in a variety of orthopedic surgical appli
Introducing the new large power line from MicroAire. Our new handpieces function as both cordless AND electric instruments, offering the ultimate in flexibility. Its the versatility the industry has
The 7600 Oscillating Saw offers unparalleled power for large bone osteotomies, thanks to its 14.4V NiMH Rechargeable Battery Pack. The cutting head may be rotated into 12 positions for cutting in any
Medicine Products: